Kim SM - Search Results

1

Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.

Zhang Y, Patel RP, Kim KH, Cho H, Jo JC, Jeong SH, Oh SY, Choi YS, Kim SH, Lee JH, Angelos M, Guruprasad P, Cohen I, Ugwuanyi O, Lee YG, Pajarillo R, Cho JH, Carturan A, Paruzzo L, Ghilardi G, Wang M, Kim S, Kim SM, Lee HJ, Park JH, Cui L, Lee TB, Hwang IS, Lee YH, Lee YJ, Porazzi P, Liu D, Lee Y, Kim JH, Lee JS, Yoon DH, Chung J, Ruella M. Zhang Y, et al. Among authors: kim sh, kim s, kim sm, kim kh, kim jh. Mol Cancer. 2023 Dec 9;22(1):200. doi: 10.1186/s12943-023-01886-9. Mol Cancer. 2023. PMID: 38066564 Free PMC article.

2

Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease.

Choi MK, Hong JY, Chang W, Kim M, Kim S, Jung HA, Lee SJ, Park S, Chung MP, Sun JM, Park K, Ahn MJ, Ahn JS. Choi MK, et al. Cancer Chemother Pharmacol. 2014 Jun;73(6):1217-25. doi: 10.1007/s00280-014-2458-0. Epub 2014 Apr 3. Cancer Chemother Pharmacol. 2014. PMID: 24696125

3

A subset of CD45+/CD19 - cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma.

Kim SM, Lee ST, Ryu KJ, Kim HJ, Kim SH, Ko YH, Kim WS, Kim SJ. Kim SM, et al. Among authors: kim hj, kim sh, kim sj, kim ws. Leuk Lymphoma. 2015;56(11):3052-7. doi: 10.3109/10428194.2015.1025391. Epub 2015 Apr 8. Leuk Lymphoma. 2015. PMID: 25739938

4

Is there any predictor for clinical outcome in EGFR mutant NSCLC patients treated with EGFR TKIs?

Lee JY, Lim SH, Kim M, Kim S, Jung HA, Chang WJ, Choi MK, Hong JY, Lee SJ, Sun JM, Ahn JS, Park K, Ahn MJ. Lee JY, et al. Cancer Chemother Pharmacol. 2014 May;73(5):1063-70. doi: 10.1007/s00280-014-2442-8. Epub 2014 Mar 25. Cancer Chemother Pharmacol. 2014. PMID: 24663503

5

Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer.

Lee JY, Lim SH, Lee MY, Kim H, Kim M, Kim S, Jung HA, Sohn I, Gil WH, Lee JE, Kim SW, Nam SJ, Ahn JS, Im YH, Park YH. Lee JY, et al. Cancer Res Treat. 2015 Oct;47(4):765-73. doi: 10.4143/crt.2014.168. Epub 2015 Jan 13. Cancer Res Treat. 2015. PMID: 25622590 Free PMC article.

6

A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test.

Choi MK, Hong JY, Chang WJ, Kim MJ, Kim SM, Jung HA, Do IG, Choi YL, Sun JM, Ahn JS, Park K, Ahn MJ. Choi MK, et al. Among authors: kim sm, kim mj. Cancer Chemother Pharmacol. 2015 Jun;75(6):1229-36. doi: 10.1007/s00280-015-2740-9. Epub 2015 Apr 23. Cancer Chemother Pharmacol. 2015. PMID: 25903122 Clinical Trial.

7

The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors.

Lee JY, Ku BM, Lim SH, Lee MY, Kim H, Kim M, Kim S, Jung HA, Sun JM, Ahn JS, Park K, Ahn MJ. Lee JY, et al. J Thorac Oncol. 2015 Jun;10(6):903-9. doi: 10.1097/JTO.0000000000000535. J Thorac Oncol. 2015. PMID: 26001141 Free article.

8

Associations between alcohol consumption and cardiovascular disease among long-term survivors of colorectal cancer: a population-based, retrospective cohort study.

Lee G, Jeong S, Choi S, Kim KH, Chang J, Kim SR, Kim K, Son JS, Kim SM, Choi D, Park SM. Lee G, et al. Among authors: kim sr, kim sm, kim kh, kim k. BMC Cancer. 2021 Jun 16;21(1):710. doi: 10.1186/s12885-021-08436-w. BMC Cancer. 2021. PMID: 34134651 Free PMC article.

9

Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study.

Lee SJ, Kim S, Kim M, Lee J, Park YH, Im YH, Park SH. Lee SJ, et al. BMC Cancer. 2015 Oct 14;15:693. doi: 10.1186/s12885-015-1716-9. BMC Cancer. 2015. PMID: 26468007 Free PMC article. Clinical Trial.

10

Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trial.

Lim SW, Park S, Kim Y, Cho JH, Park SE, Lee H, Kim HK, Kim SM, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Lim SW, et al. Among authors: kim hk, kim sm, kim y. Lung Cancer. 2018 Oct;124:293-297. doi: 10.1016/j.lungcan.2018.08.003. Epub 2018 Aug 3. Lung Cancer. 2018. PMID: 30268476 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,437 results

Search Page